Attached files
| file | filename |
|---|---|
| EX-32 - AgeX Therapeutics, Inc. | ex32.htm |
| EX-31 - AgeX Therapeutics, Inc. | ex31.htm |
| EX-21.1 - AgeX Therapeutics, Inc. | ex21-1.htm |
| 10-K - AgeX Therapeutics, Inc. | form10-k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-229432) and Form S-3 (File No. 333-251988) of AgeX Therapeutics, Inc. of our report dated March 31, 2021, relating to the consolidated financial statements of AgeX Therapeutics, Inc., which appears in this Annual Report on Form 10-K.
| /s/ OUM & Co. LLP | |
| San Francisco, California | |
| March 31, 2021 |